The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

5 articles for PR Bonneau


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain.EBI
Boehringer Ingelheim Pharmaceuticals
Novel 8-substituted dipyridodiazepinone inhibitors with a broad-spectrum of activity against HIV-1 strains resistant to non-nucleoside reverse transcriptase inhibitors.EBI
Boehringer Ingelheim (Canada)
Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases.EBI
Boehringer Ingelheim (Canada)
Heterocyclic compounds and methods for their useBDB
Novartis
Synthesis of substituted diarylmethylenepiperidines (DAMPs), a novel class of anti-HIV agents.BDB
Purdue University